ONBREZ BREEZHALER 150MCG 30 CAPSULES+1 INHALER

ONBREZ BREEZHALER 150MCG 30 CAPSULES+1 INHALER
Product Description
 
Onbrez Breezhaler 150 microgram inhalation powder, hard capsules:
Each capsule contains indacaterol maleate equivalent to 150 microgram indacaterol.
The delivered dose leaving the mouthpiece of the inhaler is indacaterol maleate equivalent to 120 microgram indacaterol.
Excipient with known effect
Each capsule contains 24.8 mg lactose.
Inhalation powder, hard capsule
Onbrez Breezhaler 150 microgram inhalation powder, hard capsules:
Transparent (uncoloured) capsules containing a white powder, with “IDL 150” printed in black above a black bar and company logo () printed in black below the black bar.
Onbrez Breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease (COPD).
The recommended dose is the inhalation of the content of one 150 microgram capsule once a day, using the Onbrez Breezhaler inhaler. The dose should only be increased on medical advice.
The inhalation of the content of one 300 microgram capsule once a day, using the Onbrez Breezhaler inhaler has been shown to provide additional clinical benefit with regard to breathlessness, particularly for patients with severe COPD. The maximum dose is 300 microgram once daily.
Onbrez Breezhaler should be administered at the same time of the day each day.
If a dose is missed the next dose should be taken at the usual time the next day.